Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892305 · ClinicalTrials.gov registry record
Hepatic Resection for Metastatic Pancreatic Cancer
A clinical trial of Neoplasm Metastasis and Pancreatic Neoplasms, sponsored by Duke University.
- Active
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT02892305 is a study of Neoplasm Metastasis and Pancreatic Neoplasms that is active but no longer recruiting, run by Duke University. The registered enrollment target is 18 participants, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02892305, a study of Neoplasm Metastasis and Pancreatic Neoplasms, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to demonstrate the feasibility of an aggressive multimodal approach among patients with stage IV pancreatic cancer (PAC) with isolated, low-volume hepatic metastasis (LVHM). We will evaluate and describe the surgical and overall outcomes of an initial cohort of subjects who undergo pancreatectomy and hepatic resection/ablation for PAC with LVHM. The end of study results will be reviewed by the Hepatiobiliary Multidisciplinary Conference (HDMC) and Surgery Audit Committee (SAC) to determine the appropriateness of adding this treatment arm for patients with oligometastatic metastatic pancreatic cancer.
Conditions Studied
Interventions
- PROCEDURE Hepatic Resection or Ablation with Pancreaticoduodenectomy
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02892305
The ClinicalTrials.gov registry entry for NCT02892305 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Neoplasm Metastasis appearing as the primary indexed condition, and to 1 intervention - of which Hepatic Resection or Ablation with Pancreaticoduodenectomy is the first listed.
NCT02892305 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02892305 about?
NCT02892305 is a clinical study titled "Hepatic Resection for Metastatic Pancreatic Cancer". The purpose of this study is to demonstrate the feasibility of an aggressive multimodal approach among patients with stage IV pancreatic cancer (PAC) with isolated, low-volume hepatic metastasis (LVHM). We will evaluate and describe the surgical and overall outcomes of an initial cohort of subjects ...
What is the current status of trial NCT02892305?
This trial is currently active not recruiting. The enrollment target is 18 participants. The study started on 2018-05-18. Estimated completion is 2027-06-30.
What conditions does trial NCT02892305 study?
This clinical trial studies the following conditions: Neoplasm Metastasis, Pancreatic Neoplasms, Liver Metastases.
What interventions are being tested in trial NCT02892305?
The interventions under investigation include: Hepatic Resection or Ablation with Pancreaticoduodenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02892305?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02892305 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm Metastasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
RECRUITING · Phase 1
-
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
RECRUITING · Phase 1
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.